Press Release – New York, NY – October 16, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented WallachBeth Capital, LLC as the sole placement agent for the recently priced $1.8 million registered direct offering of bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer.
The WallachBeth Capital team was led by Doug Bantum, Ken Bantum and Gene McNeil.
The SRFC team was led by partners Ross Carmel and Jeffrey Wofford, with associate Benjamin Sklar.